Geoff Culshaw

Dr. Geoff Culshaw

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Journal of Veterinary Cardiology
Verified
Journal Article
Closed access
JBJonathan Bouvard
Jonathan Bouvard
FTFlorence Thierry
Florence Thierry
GCGeoff Culshaw
Geoff Culshaw
TSTobias Schwarz
Tobias Schwarz
IHIan Handel
Ian Handel
YPYolanda Martinez Pereira
Yolanda Martinez Pereira

23 December 2018 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
GCGeoff Culshaw
Geoff Culshaw
HCHannah M. Costello
Hannah M. Costello
DBDavid Binnie
David Binnie
KSKevin R. Stewart
Kevin R. Stewart
ACAlicja Czopek
Alicja Czopek
MBMatthew A. Bailey
Matthew A. Bailey
Key points: Type 1 diabetes mellitus increases cardiovascular risk; hypertension amplifies this risk, while pressure natriuresis regulates long‐term blood pressure. We induced type 1 diabetes in rats by streptozotocin injection and demonstrated a substantial impairment of pressure natriuresis: acute increases in blood pressure did not increase renal medullary blood flow, tubular sodium reabsorption was not downregulated, and proximal tubule sodium reabsorption, measured by lithium clearance, was unaffected. Insulin reduced blood glucose in diabetic rats, and rescued the pressure natriuresis response without influencing lithium clearance, but did not restore medullary blood flow. Radiotelemetry showed that diastolic blood pressure was increased in diabetic rats, and its diurnal variation was reduced. Increases in medullary blood flow and decreases in distal tubule sodium reabsorption that offset acute rises in BP are impaired in early type 1 diabetes, and this impairment could be a target for preventing hypertension in type 1 diabetes. Type 1 diabetes mellitus (T1DM) substantially increases cardiovascular risk, and hypertension amplifies this risk. Blood pressure (BP) and body sodium homeostasis are linked. T1DM patients have increased total exchangeable sodium, correlating directly with BP. Pressure natriuresis is an important physiological regulator of BP. We hypothesised that pressure natriuresis would be impaired, and BP increased, in the early phase of T1DM. Male Sprague‐Dawley rats were injected with streptozotocin (30–45 mg/kg) or citrate vehicle. After 3 weeks, pressure natriuresis was induced by serial arterial ligation. In non‐diabetic controls, this increased fractional excretion of sodium from ∼1% to ∼25% of the filtered load (P < 0.01); in T1DM rats, the response was significantly blunted, peaking at only ∼3% (P < 0.01). Mechanistically, normal lithium clearance suggested that distal tubule sodium reabsorption was not downregulated with increased BP in T1DM rats. The pressure dependence of renal medullary perfusion, considered a key factor in the integrated response, was abolished. Insulin therapy rescued the natriuretic response in diabetic rats, restoring normal downregulation of tubular sodium reabsorption when BP was increased. However, the pressure dependence of medullary perfusion was not restored, suggesting persistent vascular dysfunction despite glycaemic control. Radiotelemetry showed that T1DM did not affect systolic BP, but mean diastolic BP was ∼5 mmHg higher than in non‐diabetic controls (P < 0.01), and normal diurnal variation was reduced. In conclusion, functional impairment of renal sodium and BP homeostasis is an early manifestation of T1DM, preceding hypertension and nephropathy. Early intervention to restore pressure natriuresis in T1DM may complement reductions in cardiovascular risk achieved with glycaemic control.

1 March 2015 in Seminars in Nephrology
Verified
Journal Article
Closed access
PDF file
GCGeoff Culshaw
Geoff Culshaw
IMIain M. MacIntyre
Iain M. MacIntyre
NDNeeraj Dhaun
Neeraj Dhaun
DWDavid J. Webb
David J. Webb

18 April 2013 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
GCGeoff Culshaw
Geoff Culshaw
TWT. Wagner
T. Wagner
VFVirginia Luis Fuentes
Virginia Luis Fuentes
TST. Schwarz
T. Schwarz
DYD.A. Yool
D.A. Yool
DBD.J. Brockman
D.J. Brockman

1 February 2010 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
GCGeoff Culshaw
Geoff Culshaw
AFAnne T. French
Anne T. French
RHRichard I. Han
Richard I. Han
ABAlexander Black
Alexander Black
GPGeoff T. Pearson
Geoff T. Pearson
BCBrendan M. Corcoran
Brendan M. Corcoran
Objective—To map aspects of the innervation of the mitral valve complex and determine any association with the development or progression of myxomatous mitral valve disease (MMVD) in dogs. Sample Population—Septal mitral valve leaflets from 11 dogs aged 6 months to > 10 years. Procedures—Expression of protein gene product 9.5 (general neuronal marker), tyrosine hydroxylase (adrenergic innervation marker), vasoactive intestinal peptide (parasympathetic innervation marker), and calcitonin gene–related peptide (sensory innervation marker) was assessed by use of a standard immunohistochemical technique. Innervation was assessed qualitatively and semiquantitatively. Differences between valvular zones and between groups were analyzed statistically. Results—MMVD was present in leaflets of all dogs ≥ 5 years of age. Innervation was confirmed in all leaflets but was markedly reduced in leaflets of dogs > 10 years of age. Innervation was most dense at the base of valves and mainly associated with the epimysial, perimysial, and endomysial layers of the muscle and blood vessels within the valve. Innervation was reduced within the middle zone of the valve and lacking at the free edge. Innervation was not identified at the tip of the leaflet, the free edge, or the chordae. Nerve fibers were mostly sympathetic, with the remainder being parasympathetic or sensory. Existence of MMVD did not alter the pattern or density of innervation. Conclusions and Clinical Relevance—Mitral valve leaflets in the study dogs were innervated, with most of the nerve fibers associated with the myocardium in the valve base. Development of MMVD appeared to precede the reduction of innervation associated with advancing age.

17 December 2021 in Clinical Science
Verified
Journal Article
Open access
PDF file
GCGeoff Culshaw
Geoff Culshaw
DBDavid Binnie
David Binnie
NDNeeraj Dhaun
Neeraj Dhaun
PHPatrick Hadoke
Patrick Hadoke
MBMatthew Bailey
Matthew Bailey
DWDavid J Webb
David J Webb
Hypertension is a major risk factor for cardiovascular disease. In a significant minority of people, it develops when salt intake is increased (salt-sensitivity). It is not clear whether this represents impaired vascular function or disruption to the relationship between blood pressure (BP) and renal salt-handling (pressure natriuresis, PN). Endothelin-1 (ET-1) regulates BP via ETA and ETB receptor subtypes. Blockade of ETA receptors reduces BP, but promotes sodium retention by an unknown mechanism. ETB blockade increases both BP and sodium retention. We hypothesised that ETA blockade promotes sodium and water retention by suppressing PN. We also investigated whether suppression of PN might reflect off-target ETB blockade. Acute PN was induced by sequential arterial ligation in male Sprague Dawley rats. Intravenous atrasentan (ETA antagonist, 5mg/kg) halved the normal increase in medullary perfusion and reduced sodium and water excretion by >60%. This was not due to off-target ETB blockade because intravenous A-192621 (ETB antagonist, 10mg/kg) increased natriuresis by 50% without modifying medullary perfusion. In a separate experiment in salt-loaded rats monitored by radiotelemetry, oral atrasentan reduced systolic and diastolic BP by ~10mmHg, but additional oral A-192621 reversed these effects. Endogenous ETA stimulation has natriuretic effects mediated by renal vascular dilation while endogenous ETB stimulation in the kidney has antinatriuretic effects via renal tubular mechanisms. Pharmacological manipulation of vascular function with ET antagonists modifies the BP set-point, but even highly selective ETA antagonists attenuate PN, which may be associated with salt and water retention.